Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
Recombinant mouse IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Recombinant mouse IgG1 Monoclonal Antibody.
Clone: 4G7.
Isotype: Mouse IgG1 kappa.
Source: The anti-human CD19 monoclonal antibody (clone: 4G7) was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: 4G7) specifically binds to the human CD19 protein.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the human CD19 protein.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.
Background
The 4G7 antibody binds to the human CD19 protein, a transmembrane protein expressed in all B lineage cells including human plasma cells. CD19 plays two major roles in human B cells: it acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane, and works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling pathways. CD19 is a biomarker for B lymphocyte development, lymphoma diagnosis and can be utilized as a target for leukemia immunotherapies.
IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases.
Hörner, S., et al. (2022). Cancers (Basel). 2022 Aug 16;14(16):3941. doi: 10.3390/cancers14163941. PMID: 36010934
The study utilized codon-optimized variable domains of humanized Apo-1, 2H7, 4G7 (anti-human CD19), and MOPC-21 antibodies for transfection into CHO cells. Bispecific antibodies combined the CD95 agonist Apo-1 with either anti-CD20 (clone 2H7) or anti-CD19 (clone 4G7) in F(ab)2 and single-chain formats. The CD19 binding affinity showed an EC50 of approximately 7.5 nM, despite 4G7’s higher affinity compared to 2H7. Flow cytometry revealed CD20 expression was 3–10-fold higher than CD19, with Raji cells expressing over 20,000 CD19 and 190,000 CD20 molecules per cell.
Tags: 4G7 antibody for flow cytometry; 4G7 monoclonal antibody
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody.
Seidel, U. J., et al. (2016). Mol Ther. 2016 Sep 6;24(9):1634-43. doi: 10.1016/j.ymthe.2016.06.008. PMID: 27380762
The Fc-optimized CD19 antibody 4G7SDIE, a humanized version of the murine 4G7 antibody (anti-human CD19) with S239D and I332E modifications, was tested in B-lineage ALL blasts from 18 patients and 5 4G7SDIE-treated patients. The antibody was detected via indirect immunofluorescence staining and flow cytometry. 4G7SDIE enhanced antibody-dependent cellular cytotoxicity (ADCC) against leukemic blasts, showing promise for minimal residual disease (MRD) treatment due to favorable target-to-effector cell ratios.
Tags: anti-human CD19 4G7 mAb for flow cytometry; anti-human CD19 4G7 of low endotoxin
Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells.
Kellner, C., et al. (2011). Cancer Lett. 2011 Jul 28;306(1):88-95. doi: 10.1016/j.canlet.2011.02.023. PMID: 21339041
The study utilized the 4G7 hybridoma (anti-human CD19; IgG1) and 3G8 (CD16; IgG1) to create Fab–scFv fusion proteins combining CD19-directed Fab fragments with CD19 and CD16 scFvs. CD19, a 95 kDa transmembrane glycoprotein, is a promising target for B-cell malignancy treatments due to its favorable properties. The bispecific antibodies demonstrated effective antibody-dependent cellular cytotoxicity (ADCC) against B-lymphoid tumor cells, highlighting CD19’s potential in immunotherapy.
Tags: anti-CD19 (4G7) monoclonal antibody; human CD19 antibody (clone 4G7)
Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia.
Horton, H. M., et al. (2008). Cancer Res. 2008 Oct 1;68(19):8049-57. doi: 10.1158/0008-5472.CAN-08-1265. PMID: 18829563
The study developed XmAb5574, a humanized and affinity-matured version of the mouse anti-CD19 antibody 4G7 with S239D/I332E Fc modifications. XmAb5574 and other anti-CD19 antibodies showed approximately 2-fold higher binding affinity than 4G7. In vitro, target cells opsonized with antibodies were mixed with NK cells, and LDH release was measured. In vivo, fluorescence-activated cell sorting confirmed CD19 expression and tumor cell percentages, demonstrating potent activity against lymphoma and leukemia.
Tags: anti-human CD19 4G7 in animal model; anti-human CD19 4G7 mAb for flow cytometry
For more references about anti-human CD19 antibody (4G7), please contact our scientific support team with message@sydlabs.com.
Syd Labs provides the following in vivo grade recombinant anti-mouse CD19 monoclonal antibodies:
Recombinant Anti-mouse CD19 monoclonal antibody (Clone: 1D3)
Syd Labs provides the following in vivo grade recombinant anti-human CD19 monoclonal antibodies:
Recombinant Anti-human CD19 monoclonal antibody (Clone: SJ25C1)
Recombinant Anti-human CD19 monoclonal antibody (Clone: B43)
Recombinant Anti-human CD19 monoclonal antibody (Clone: FMC63)
Syd Labs provides the following recombinant anti-mouse CD19 monoclonal antibodies for flow cytometry:
Recombinant Anti-mouse CD19 monoclonal antibody (Clone: 1D3) for flow cytometry
Syd Labs provides the following recombinant anti-human CD19 monoclonal antibodies for flow cytometry:
Recombinant Anti-human CD19 monoclonal antibody (Clone: SJ25C1) for flow cytometry
Recombinant Anti-human CD19 monoclonal antibody (Clone: FMC63) for flow cytometry
Recombinant Anti-human CD19 monoclonal antibody (Clone: B43) for flow cytometry
Copyright © 2009-2025 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.
Friend Link: Ushelf